Dual-phase contrast-enhanced CT evaluation of dural arteriovenous fistula in patients with pulsatile tinnitus as an initial symptom. Issue 148 (March 2022)

• Record Type: Journal Article
• Authors: Li, Xiaoshuai; Xu, Ning; Meng, Xuxu; Dai, Chihang; Qiu, Xiaoyu; Ding, Heyu; Lv, Han; Zeng, Rong; Xie, Jing; Zhao, Pengfei; Yang, Zhenghan; Gong, Shusheng; Wang, Zhenchang
• Is Part Of: European journal of radiology. Issue 148(2022)
• Publication Date: 2022-03
• Subjects: Dual-phase contrast-enhanced CT -- Dural arteriovenous fistula -- Pulsatile tinnitus; Medical radiology -- Periodicals; Radiology -- Periodicals; Radiologie médicale -- Périodiques; Medical radiology; Periodicals; 616.075705
• DOI: 10.1016/j.ejrad.2021.110137
• Languages: English
• ISSNs: 0720-048X

Abstract

Highlights: DAVF is not rare in patients with PT as the initial symptom. Dual-phase contrast-enhanced CT can be used for screening DAVF in patients with PT. Asymmetric ECA branches and asymmetric enhancement of venous sinus have high sensitivity and specificity. Shaggy venous sinus and numerous transcalvarial channels have high specificity. Abstract: Purpose: Intracranial dural arteriovenous fistula (DAVF) can cause pulsatile tinnitus (PT). The purpose of this study was to investigate the diagnostic performance of dual-phase contrast-enhanced CT (DP-CECT) for DAVF in PT patients compared with digital subtraction angiography (DSA). Method: From February 2015 to April 2021, PT patients undergoing routine DSA examination were prospectively analyzed. Patients with and without DAVF diagnosed by DSA were included. In DP-CECT, the radiological signs related to DAVF were assessed as follows: asymmetric external carotid artery (ECA) branches, asymmetric enhancement of intracranial or extracranial veins, asymmetric venous collaterals in extracranial space, and shaggy tentorium or venous sinus on CTA; asymmetric enhancement of intracranial or extracranial veins on CTV; numerous transcalvarial channels and asymmetric size of foramen spinosum on high-resolution CT (HRCT). Results: 253 PT patients receiving DSA were enrolled, and these patients had previously been screened by DP-CECT. Forty-six patients were diagnosed as DAVF by DSA. Therefore, the prevalence of DAVF was 18% (46/253) in patients with PT as the initial symptom. The sensitivity and specificity of DP-CECT for diagnosis of DAVF were 96% and 100%. The sensitivity of individual CTA signs ranged from 65% to 93%, and specificities ranged from 83% to 100%. The sensitivity of CTV sign was 80%, and specificity was 100%. The sensitivity of individual HRCT signs ranged from 48 to 52% and specificities from 61 to 100%. Conclusions: DAVF is not rare in patients with PT as the initial symptom. DP-CECT can be used for screening DAVF in patients with PT.